Stanozolol - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for stanozolol and what is the scope of patent protection?
Stanozolol
is the generic ingredient in one branded drug marketed by Lundbeck Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for stanozolol.
Summary for stanozolol
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 1 |
Patent Applications: | 4,891 |
DailyMed Link: | stanozolol at DailyMed |
Recent Clinical Trials for stanozolol
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for stanozolol
Anatomical Therapeutic Chemical (ATC) Classes for stanozolol
US Patents and Regulatory Information for stanozolol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lundbeck Inc | WINSTROL | stanozolol | TABLET;ORAL | 012885-001 | May 14, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for stanozolol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lundbeck Inc | WINSTROL | stanozolol | TABLET;ORAL | 012885-001 | May 14, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |